July 22, 2026 · Form 4 insider transaction
Giltner Richard bought 760 shares of United Therapeutics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.; Annual non-employee director award.; Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.; Not applicable as restricted stock units do not have an expiration date.